AMENDMENT NO. 2 TO SENIOR SECURED CONVERTIBLE PROMISSORY NOTESenior Secured Convertible Promissory Note • August 16th, 2024 • Arch Therapeutics, Inc. • Surgical & medical instruments & apparatus
This Amendment No. 2 (this “Amendment”) to those certain Senior Secured Convertible Promissory Notes (the “First Notes”), issued by Arch Therapeutics, Inc., a Nevada corporation (the “Company”), to each Holder pursuant to that certain Securities Purchase Agreement, dated May 15, 2024, by and among the Company and the signatories thereto (the “Holders”) (the “Securities Purchase Agreement”) is made and entered into effective August 15, 2024 by and among the Company and the Consenting Stockholders (as defined below). Capitalized terms used herein but not otherwise defined shall have the meanings ascribed to them in the Securities Purchase Agreement.
